We recently compiled a list of the Jim Cramer Discusses 17 Stocks And Blasts Zero Day Options. In this article, we are going ...

Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory ...

I HAVE been called many things but I rather intend to be forgotten.” So said Dominique Pelicot as he ­prepared to be ...

Novo Nordisk’s shares fell sharply on Friday as disappointing results from tests of its latest obesity drug wiped about €90bn off the valuation of Europe’s largest company by market capitalisation.

FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in ...

"They think of them like diet pills, so once they lose weight they ... are prescribed to treat Type 2 diabetes -- but not obesity. Lilly, which makes tirzepatide, earlier this month announced ...

No surprise that what was described as the first clinical comparative effectiveness study of tirzepatide (Mounjaro, Eli Lilly ... weight and make changes in diet and exercise habits.

Eli Lilly has asked to join in opposing a lawsuit brought by compounding pharmacies against the U.S. Food and Drug ...

Musk revealed using Novo Nordisk's Ozempic and Eli Lilly's Mounjaro, highlighting their popularity for weight management.

Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by joining as a defendant, stating it wants to end the “entitlement” some ...

Imagine if you could eat your fill on Christmas day then dial down your appetite for January. Good news: such a prospect may ...